Minerva Surgical, Inc.
UTRS
Rank in Stocks
#34999
Minerva Surgical, Inc. functions as a commercial-stage medical technology... Minerva Surgical, Inc. functions as a commercial-stage medical technology enterprise, specializing in the creation, production, and distribution of innovative, minimally invasive solutions tailored to address the uterine healthcare needs of women throughout the United States. Their suite of offerings features advanced endometrial ablation systems, including the Minerva ES and Genesys HTA. They also provide the Symphion Tissue Removal System, a sophisticated, minimally invasive device for uterine tissue removal that uniquely integrates bladeless tissue resection, coagulation capabilities, continuous visualization during procedures, and precise intrauterine pressure monitoring. Additionally, the Resectr Tissue Resection Device is a handheld surgical tool engineered for the hysteroscopic removal and diagnostic evaluation of endometrial polyps. These specialized instruments are utilized by obstetrician-gynecologists across a variety of clinical settings, such as hospitals, outpatient ambulatory surgical centers, and private physician practices. The company was founded in 2008 and is headquartered in Santa Clara, California.
Share Price
$0.0001
Last synced: 2026-11-10
Market Cap
$887.30
Change (1 day)
0.00%
Change (1 year)
-90.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Minerva Surgical, Inc. (UTRS)
Category
Healthcare
EPS for Minerva Surgical, Inc. (UTRS)
EPS as of September 2023 TTM: $-6.61
According to Minerva Surgical, Inc.'s latest financial reports, its current EPS (TTM) is $-6.61. At the end of 2022 the company had an EPS of $-23.68, a decrease compared to its 2021 EPS of $-14.98.
EPS history for Minerva Surgical, Inc. from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-6.61 | -72.09% |
| 2022 | $-23.68 | 58.08% |
| 2021 | $-14.98 | -16.36% |
| 2020 | $-17.91 | -76.21% |
| 2019 | $-75.29 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $3.86 | -158.40% |
US
|
|
| $1.64 | -124.81% |
US
|
|
| $-1.05 | -84.11% |
US
|
|
| $1.79 | -127.11% |
AU
|
|
| $2.08 | -131.47% |
US
|
Questions about Minerva Surgical, Inc.'s earnings per share (EPS)
What is Minerva Surgical, Inc.'s earnings per share (EPS)?
Minerva Surgical, Inc.'s earnings per share (EPS) over the last twelve months is $-6.61, as of Sep 2023.
What was Minerva Surgical, Inc.'s earnings per share (EPS) in 2022?
In 2022, Minerva Surgical, Inc.'s earnings per share (EPS) was $-23.68, compared with $-14.98 in 2021.
How has Minerva Surgical, Inc.'s earnings per share (EPS) changed since 2019?
From 2019 to 2022, Minerva Surgical, Inc.'s earnings per share (EPS) was highest in 2021 ($-14.98) and lowest in 2019 ($-75.29).
How does Minerva Surgical, Inc.'s earnings per share (EPS) compare with similar companies?
Minerva Surgical, Inc.'s earnings per share (EPS) ($-6.61) is lower than that of all 5 similar companies listed above. The highest among them is GE HealthCare Technologies Inc., with $3.86.